Clinical Performance of Dual-cantilevered Single-implant Bridge

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Bern

About this trial

The study aims to evaluate the clinical performance (implant and prosthetic survival/ success rates) of a novel implant-supported fixed dental prosthesis design: the dual-cantilevered single implant bridge (T-Bridge) made out of monolithic zirconia bonded to a titanium base abutment (Variobase abutments)

Eligibility criteria

Qualifiers

Age ≥ 20 years

Willingness to sign an informed consent and participate in the study

Three missing adjacent teeth in the posterior site.

Tooth gap of 21-24 mm.

Disqualifiers

Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol

Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates.

Pregnancy or lactation

Heavy smoking habit with ≥ 10 cig/d

Trial design

Treatments tested in this trial

  • Dual-cantilevered implant bridge
  • 3-unit iFDP

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Bern

Lead sponsor

ITI International Team for Implantology, Switzerland

Collaborator